Andrew Saik
CFO
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arvinas, Inc. (ARVN) | Chief Financial Officer and Treasurer | $542,063 | $3,362,314 |
| 2024 | Arvinas, Inc. (ARVN) | Chief Financial Officer and Treasurer | $272,596 | $3,465,996 |
| 2020 | Yarrow Bioscience, Inc. (YARW) | Chief Financial Officer and Treasurer | $309,722 | $1,536,537 |
| 2019 | Yarrow Bioscience, Inc. (YARW) | Chief Financial Officer and Treasurer | — | — |
Executive changes
-
Appointed chief financial officer, treasurer and principal financial officer at Arvinas, Inc. (ARVN)2024-06-24
Earnings-call appearances
-
Arvinas, Inc. Q1 FY2026 Earnings Call2026-05-12
Arvinas, Inc. (ARVN)
-
Arvinas, Inc. Q4 FY2025 Earnings Call2026-02-24
Arvinas, Inc. (ARVN)
-
Arvinas, Inc. Q3 FY2025 Earnings Call2025-11-05
Arvinas, Inc. (ARVN)
-
Arvinas, Inc. Q2 FY2025 Earnings Call2025-08-06
Arvinas, Inc. (ARVN)
-
Arvinas, Inc. Q1 FY2025 Earnings Call2025-05-01
Arvinas, Inc. (ARVN)
-
Arvinas, Inc. Q4 FY2024 Earnings Call2025-02-11
Arvinas, Inc. (ARVN)
-
VYNE Therapeutics Inc. Q1 FY2021 Earnings Call2021-05-06
Yarrow Bioscience, Inc. (YARW)
-
VYNE Therapeutics Inc. Q3 FY2020 Earnings Call2020-11-05
Yarrow Bioscience, Inc. (YARW)
-
VYNE Therapeutics Inc. Q2 FY2020 Earnings Call2020-08-06
Yarrow Bioscience, Inc. (YARW)
-
VYNE Therapeutics Inc. Q1 FY2020 Earnings Call2020-05-11
Yarrow Bioscience, Inc. (YARW)